Cases & Deals

Invesco Perpetual invests in DrugDev

Clients Invesco Perpetual

Jones Day advised Invesco Perpetual in connection with its $50 million investment in DrugDev Inc., an interactive network and data sharing platform for trial doctors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.